NASSIMA TIOURIRINE, MD
Psychiatric at Hospital Dr, Charlottesville, VA
License number
Virginia 0101245923
Category
Psychiatric
Type
Psychiatry
Address
Address
3 Hospital Dr, Charlottesville, VA 22908
Phone
(434) 234-7381
(434) 982-1853 (Fax)
(434) 982-1853 (Fax)
Personal information
See more information about NASSIMA TIOURIRINE at radaris.comName
Address
Phone
465 Foxdale Ln, Charlottesvle, VA 22903
Crozet, VA
385 Stone Creek Pt, Charlottesvle, VA 22902
465 Foxdale Ln, Charlottesvle, VA 22903
Professional information
See more information about NASSIMA TIOURIRINE at trustoria.com
Dr. Nassima Tiouririne - MD (Doctor of Medicine)
Dr. Nassima Tiouririne - MD (Doctor of Medicine)
Hospitals:
Charlottesville Office
1215 Lee St, Charlottesville 22908
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
Charlottesville Office
1215 Lee St, Charlottesville 22908
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
1215 Lee St, Charlottesville 22908
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
Charlottesville Office
1215 Lee St, Charlottesville 22908
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
Method, Computer Program Product And System For Individual Assessment Of Alcohol Sensitivity
Method, Computer Program Product And System For Individual Assessment Of Alcohol Sensitivity
US Patent:
2011026, Oct 27, 2011
Filed:
Aug 20, 2008
Appl. No.:
12/674348
Inventors:
Bankole A. Johnson - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Marc D. Breton - Charlottesville VA, US
Boris P. Kovatchev - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Marc D. Breton - Charlottesville VA, US
Boris P. Kovatchev - Charlottesville VA, US
Assignee:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION - Charlottesville VA
International Classification:
G06F 19/00
US Classification:
702 19
Abstract:
Methods/computer methods and systems/computer systems for the evaluation of two idiosyncratic indices of alcohol intoxication: the Alcohol Sensitivity Index (ASI), and the brain-specific Cognitive Alcohol Sensitivity Index (CASI). The two indices are based on the new Metabolic and Cognitive Minimal Models of Alcohol Dynamics, and are derived from specific clinical protocols, accompanied by specific data analysis procedures. The two indices may be derived from specific clinical and cognitive assessment protocols, accompanied by specific data analysis procedures based on the new metabolic and cognitive minimal models of alcohol dynamics.
Combined Effects Of Topiramate And Ondansetron On Alcohol Consumption
Combined Effects Of Topiramate And Ondansetron On Alcohol Consumption
US Patent:
2010004, Feb 18, 2010
Filed:
Dec 19, 2007
Appl. No.:
12/520095
Inventors:
Bankole A. Johnson - Keswick VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Assignee:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION - Charlottesville VA
International Classification:
A61K 31/439, A61K 31/4178, A61K 31/35
US Classification:
514282, 514397, 514455
Abstract:
The present invention provides for the use of combinations of drugs to treat addictive disorders. More specifically, the present invention relates the use of drugs in conjunction with behavioral intervention to treat alcohol-related diseases and disorders as well as treatment of obesity and regulating weight.
Medication Combinations For The Treatment Of Alcoholism And Drug Addiction
Medication Combinations For The Treatment Of Alcoholism And Drug Addiction
US Patent:
2011006, Mar 17, 2011
Filed:
May 20, 2008
Appl. No.:
12/675486
Inventors:
Bankole A. Johnson - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Wendy J. Lynch - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Wendy J. Lynch - Charlottesville VA, US
Assignee:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION - Charlottesville VA
International Classification:
A61K 31/485, A61K 31/55, A61K 31/551, A61K 31/519, A61K 31/496, A61K 31/56, A61K 38/02, A61P 25/30, A61P 25/32, A61P 25/36, A61P 3/04
US Classification:
514 11, 514282, 514215, 514221, 51425941, 51425304, 51425307, 514171
Abstract:
The present invention provides for the use of combinations of drugs to treat addictive disorders. More specifically, the present invention provides compositions and methods for treating disorders using combinations of drugs such as topiramate, ondansetron, and naltrexone.
Topiramate Plus Naltrexone For The Treatment Of Addictive Disorders
Topiramate Plus Naltrexone For The Treatment Of Addictive Disorders
US Patent:
2012030, Nov 29, 2012
Filed:
Aug 8, 2012
Appl. No.:
13/569465
Inventors:
Bankole A. Johnson - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Wendy J. Lynch - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Wendy J. Lynch - Charlottesville VA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 31/485, A61P 25/36, A61P 25/34, A61P 25/30, A61P 25/32
US Classification:
514282
Abstract:
The present invention provides for the use of combinations of drugs to treat addictive disorders.
Topiramate Plus Naltrexone For The Treatment Of Addictive Disorders
Topiramate Plus Naltrexone For The Treatment Of Addictive Disorders
US Patent:
2010007, Mar 25, 2010
Filed:
Jan 31, 2008
Appl. No.:
12/525320
Inventors:
Bankole A. Johnson - Keswick VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Wendy J. Lynch - Charlottesville VA, US
Nassima Ait-Daoud Tiouririne - Charlottesville VA, US
Wendy J. Lynch - Charlottesville VA, US
Assignee:
UNIVERSITY OF VIRGINIA PATENT FOUNDATION - Charlottesville VA
International Classification:
A61K 31/485, A61K 31/357, A61K 31/4178
US Classification:
514282, 514455, 514397
Abstract:
The present invention provides for the use of combinations of drugs to treat addictive disorders.